Industry News - Tag: TGA
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
8 February 2021
Australia is set to switch the antihistamine bilastine from prescription to non-prescription status.
16 December 2020
Australia’s Therapeutic Goods Administration (TGA) has now given the final go-ahead for certain low-dose cannabidiol (CBD) medicines to be sold without a prescription. However, the TGA has made a number of changes to its interim decision released in September 2020.